According to an ACR release, more than 220,000 people will be diagnosed with lung cancer in 2018 and nearly 160,000 will die from the disease. That exceeds all combined deaths from breast, colon and prostate cancer.
University College London Hospital (UCLH) and the Alan Turing Institute in London have entered a three-year partnership to allow artificial intelligence (AI) to perform a variety of clinical tasks otherwise done by nurses and physicians.
A team of scientists found therapeutic treatment using radiopharmaceutical I-131 mIBG can effectively mitigate symptoms of certain neuroendocrine tumors and resulted in improved prognosis for patients with symptomatic improvement, radiographic response or stability and biochemical response.
A new discovery involving diamonds may significantly cut costs related to medical imaging and drug-discovery devices, according to a team of researchers led by the U.S. Department of Energy and the University of California, Berkeley.
A team of German researchers used PET/CT and modeling practices to create a new method to model and predict tumor response in radioligand therapy (RLT), which authors say is the first attempt to do so.
New ultrasound guidelines can accurately identify pediatric patients who should undergo biopsy for thyroid cancer, according to recent research presented at the Society for Pediatric Radiology’s annual meeting in Nashville, Tennessee.
In a recent paper from consulting firm Deloitte, experts argue that evolving digital technology—notably artificial intelligence (AI)—has the potential to create jobs in many areas of healthcare, including diagnostic radiology.
The "disease screening pill," developed by researchers from the University of Michigan, lit up malignant tumors in mice when exposed to near-infrared light—all without the use of radiation, according to a study published in Molecular Pharmaceutics.
On May 17, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the Value Initiative Industry Alliance—a collaboration among corporate community members that will help implement the organization’s Value Initiative and advance nuclear medicine.
Only two percent of heavy smokers—those who smoke a pack a day—in the U.S. currently get lung cancer screenings, according to a recent press release from the American Society of Clinical Oncology (ASCO).